Curonix

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Curonix sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).

5 total trials 2 currently recruiting 2 completed upper quartile by trial count

Curonix: 5 sponsored US clinical trials, 2 recruiting.

Curonix sponsors 5 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 2 completed. The most-studied condition in this pipeline is Chronic Pain, with 2 trials.

Upper-quartile sponsor footprint

Curonix sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Open and recent trials

5 total, page 1 of 1

RECRUITING NA

Retrospective-Prospective PNS Study

NCT06845631
RECRUITING NA

Freedom-1 Study for Chronic Knee Pain

NCT03877653
ACTIVE NOT RECRUITING

Retrospective PNS Study

NCT06832449
COMPLETED NA

Clinical Trial of Wireless CranioFacial Nerve Stimulation (CFNS) for the Treatment of CranioFacial Neuropathic Pain

NCT02729480
COMPLETED NA

Wireless Spinal Cord Stimulation for Chronic Pain

NCT02514590

Therapeutic Areas

Chronic Pain 2
Osteoarthritic Knee Pain 1

What is open in the Curonix pipeline

2 recruiting of 5 indexed (40% open); 2 completed (40%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Chronic Pain (2 trials), 1 other listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Curonix: open-pipeline peers nationwide

Peers matched on 5 registered trials and 40% open enrollment, not the therapeutic-area sidebar.

Curonix sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 4681012 0%10%20%30%40%50% Total trials Recruiting share Curonix4YouandMeAbbott Rapid DxAccess Business GroupAcera SurgicalAd scientiamAlto NeuroscienceBonafide HealthBrooks Rehabilitation
Curonix sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Curonix sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 5 trials (± recruiting share)

Sponsors near 40% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Curonix page

5 registered trials is a research-attention snapshot, not an endorsement of Curonix or any single study.

  • 2 of Curonix's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Chronic Pain is the condition Curonix studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Chronic Pain trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Curonix pipeline card: 5 registered trials from official public datasets.Report a data error.